Details of what could be a breakthrough preventative drug for HIV were unveiled at the AIDS 2024 summit in Munich last month.
Paul Sax is a Professor of Medicine at Harvard Medical School, and the clinical director of the Division of Infectious Diseases at Brigham and Women's Hospital.
He's recently returned from the summit, and he joins Emile Donovan from Boston.
Photo: Copyright: lightfieldstudios
